MARK E. DELANEY - 21 Oct 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
SVP & Chief Commercial Officer
Signature
Sean D. Mersten, Attorney in Fact for Mark E. Delaney
Issuer symbol
DGX
Transactions as of
21 Oct 2024
Transactions value $
$598
Form type
4
Filing time
25 Oct 2024, 16:27:11 UTC
Previous filing
26 Jul 2024
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Small acquisition under Rule 16a-6 $598 +4 +0.08% $149.39 5.02K 21 Oct 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted share units.
F2 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.